A novel small molecule YAP inhibitor, CA3, has demonstrated the potential to inhibit tumor growth in multiple cancers, including esophageal adenocarcinoma, pancreatic cancer, and osteosarcoma.148, 149, 150. Here, YAP1 is linked to neoplasm.